Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

<div>Diameter, polydispersity index, and zeta potential of the nanoparticles during 50 days: (a) empty nanoparticles; (b) nanoparticles containing enoxaparin.</div>

Journal of Nanotechnology

fig1

Figure 1

Figure 1: Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis 

Figure 1 | Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis 